Skip to main content
Fig 1 | BMC Cardiovascular Disorders

Fig 1

From: Resveratrol ameliorates myocardial fibrosis by inhibiting ROS/ERK/TGF-β/periostin pathway in STZ-induced diabetic mice

Fig 1

Body weight and blood glucose levels in different groups. a Protocol for the induction of diabetes and the treatment of resveratrol. b Body weight in non-diabetic, diabetic and resveratrol-treated diabetic mice. c Blood glucose in non-diabetic, diabetic and resveratrol-treated diabetic mice. n = 8 in each group; *p < 0.05 vs DM group; **p < 0.01 vs DM group

Back to article page

BMC Cardiovascular Disorders

ISSN: 1471-2261

Contact us